BACKGROUND: Excess adiposity is associated with greater systemic inflammation. Whether visceral adiposity is more proinflammatory than subcutaneous abdominal adiposity is unclear. METHODS AND RESULTS: We examined the relations of abdominal subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT), assessed by multidetector computerized tomography, to circulating inflammatory and oxidative stress biomarkers in 1250 Framingham Heart Study participants (52% women; age 60+/-9 years). Biomarkers were examined in relation to increments of SAT and VAT after adjustment for age, sex, smoking, physical activity, menopause, hormone replacement therapy, alcohol, and aspirin use; additional models included body mass index and waist circumference. SAT and VAT were positively and similarly (with respect to strength of association) related to C-reactive protein, fibrinogen, intercellular adhesion molecule-1, interleukin-6, P-selectin, and tumor necrosis factor receptor-2 (multivariable model R2 0.06 to 0.28 [SAT] and 0.07 to 0.29 [VAT]). However, compared with SAT, VAT was more highly associated with urinary isoprostanes and monocyte chemoattractant protein-1 (SAT versus VAT comparison: isoprostanes, R2 0.07 versus 0.10, P=0.002; monocyte chemoattractant protein-1, R2 0.07 versus 0.08, P=0.04). When body mass index and waist circumference were added to the models, VAT remained significantly associated with only C-reactive protein (P=0.0003 for women; P=0.006 for men), interleukin-6 (P=0.01), isoprostanes (P=0.0002), and monocyte chemoattractant protein-1 (P=0.008); SAT only remained associated with fibrinogen (P=0.01). CONCLUSIONS: The present cross-sectional data support an association between both SAT and VAT with inflammation and oxidative stress. The data suggest that the contribution of visceral fat to inflammation may not be completely accounted for by clinical measures of obesity (body mass index and waist circumference).
BACKGROUND: Excess adiposity is associated with greater systemic inflammation. Whether visceral adiposity is more proinflammatory than subcutaneous abdominal adiposity is unclear. METHODS AND RESULTS: We examined the relations of abdominal subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT), assessed by multidetector computerized tomography, to circulating inflammatory and oxidative stress biomarkers in 1250 Framingham Heart Study participants (52% women; age 60+/-9 years). Biomarkers were examined in relation to increments of SAT and VAT after adjustment for age, sex, smoking, physical activity, menopause, hormone replacement therapy, alcohol, and aspirin use; additional models included body mass index and waist circumference. SAT and VAT were positively and similarly (with respect to strength of association) related to C-reactive protein, fibrinogen, intercellular adhesion molecule-1, interleukin-6, P-selectin, and tumor necrosis factor receptor-2 (multivariable model R2 0.06 to 0.28 [SAT] and 0.07 to 0.29 [VAT]). However, compared with SAT, VAT was more highly associated with urinary isoprostanes and monocyte chemoattractant protein-1 (SAT versus VAT comparison: isoprostanes, R2 0.07 versus 0.10, P=0.002; monocyte chemoattractant protein-1, R2 0.07 versus 0.08, P=0.04). When body mass index and waist circumference were added to the models, VAT remained significantly associated with only C-reactive protein (P=0.0003 for women; P=0.006 for men), interleukin-6 (P=0.01), isoprostanes (P=0.0002), and monocyte chemoattractant protein-1 (P=0.008); SAT only remained associated with fibrinogen (P=0.01). CONCLUSIONS: The present cross-sectional data support an association between both SAT and VAT with inflammation and oxidative stress. The data suggest that the contribution of visceral fat to inflammation may not be completely accounted for by clinical measures of obesity (body mass index and waist circumference).
Authors: John R Koethe; Aihua Bian; Ayumi K Shintani; M Sean Boger; Valerie J Mitchell; Husamettin Erdem; Todd Hulgan Journal: AIDS Res Hum Retroviruses Date: 2012-02-02 Impact factor: 2.205
Authors: Ryo Nakazato; Haim Shmilovich; Balaji K Tamarappoo; Victor Y Cheng; Piotr J Slomka; Daniel S Berman; Damini Dey Journal: J Cardiovasc Comput Tomogr Date: 2011-03-21
Authors: Mengmeng Du; Jennifer Prescott; Peter Kraft; Jiali Han; Edward Giovannucci; Susan E Hankinson; Immaculata De Vivo Journal: Am J Epidemiol Date: 2012-02-01 Impact factor: 4.897
Authors: Balaji Tamarappoo; Damini Dey; Haim Shmilovich; Ryo Nakazato; Heidi Gransar; Victor Y Cheng; John D Friedman; Sean W Hayes; Louise E J Thomson; Piotr J Slomka; Alan Rozanski; Daniel S Berman Journal: JACC Cardiovasc Imaging Date: 2010-11
Authors: Nell A Bekiares; Andrea S Chen; Dhanansayan Shanmuganayagam; Adrienne Dardenne Meyers; Thomas D Crenshaw; Christian G Krueger; Jess D Reed Journal: Comp Med Date: 2017-12-01 Impact factor: 0.982
Authors: Morgan R Chojnacki; Hannah D Holscher; Alaina R Balbinot; Lauren B Raine; John R Biggan; Anne M Walk; Arthur F Kramer; Neal J Cohen; Charles H Hillman; Naiman A Khan Journal: Early Hum Dev Date: 2019-01-12 Impact factor: 2.079
Authors: Michael G S Shashaty; Esra Kalkan; Scarlett L Bellamy; John P Reilly; Daniel N Holena; Kathleen Cummins; Paul N Lanken; Harold I Feldman; Muredach P Reilly; Jayaram K Udupa; Jason D Christie Journal: Crit Care Med Date: 2014-07 Impact factor: 7.598